Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 26;14(12):e089819.
doi: 10.1136/bmjopen-2024-089819.

Longitudinal cholesterol trends across socioeconomic groups in Norway: the influence of lipid-lowering drugs in the population-based Tromsø Study 1994-2016

Chi Quynh Vo  1   2 , Tom Wilsgaard  3 , Per-Jostein Samuelsen  3   4 , Ellisiv B Mathiesen  5 , Hilde L Sommerseth  6 , Anne Elise Eggen  3 , Torbjørn Wisløff  7
Affiliations

Longitudinal cholesterol trends across socioeconomic groups in Norway: the influence of lipid-lowering drugs in the population-based Tromsø Study 1994-2016

Chi Quynh Vo et al. BMJ Open. .

Abstract

Objectives: There is limited evidence regarding the impact of lipid-lowering drugs (LLDs) on the socioeconomic gradient in a longitudinal perspective. The study investigates the longitudinal socioeconomic gradient in total cholesterol levels and whether this is affected by the use of LLDs.

Design: Population-based cohort study.

Setting: Sample from adult inhabitants of Tromsø municipality, Norway, who participated in the Tromsø Study (1994-2016).

Participants: 17 550 participants of the population-based Tromsø Study in 1994-1995 who were non-users of LLD, aged 25-78 years at baseline and who attended one or more of three subsequent surveys in 2001, 2007-2008 and 2015-2016 were included in the study.

Outcome measure: Socioeconomic gradient in total cholesterol levels was compared among participants treated and not treated with LLDs during the observation period.

Results: The total cholesterol levels across all educational groups increased from 1994-1995 to 2015-2016 among untreated women (+0.33 mmol/L to +0.48 mmol/L), except for those with primary education (-0.12 mmol/L). Total cholesterol levels decreased among untreated men (-0.40 mmol/L to -0.06 mmol/L, from lowest education to highest education), treated women (-1.88 mmol/L to -1.35 mmol/L) and men (-2.21 mmol/L to -1.84 mmol/L) across all educational groups. At baseline, we observed a significant inverse association between education and total cholesterol levels among non-users of LLDs. There was no clear educational gradient in total cholesterol levels among users of LLDs.

Conclusions: Users of LLDs experienced a more substantial decrease in total cholesterol levels over time compared with non-users. The educational gradient in total cholesterol levels observed among non-users of LLD was not apparent among users.

Keywords: Cardiovascular Disease; Drug Therapy; EPIDEMIOLOGIC STUDIES; EPIDEMIOLOGY; Risk Factors.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. Flowchart of the participants. The Tromsø study 1994–2016. LLDs, lipid-lowering drug
Figure 2
Figure 2. Observed estimated mean longitudinal cholesterol (mmol/L) in women and men over surveys and education among non-user of lipid-lowering drugs (LLD) (A and B) and user of lipid-lowering drugs from 2001 (Tromsø5) to 2015–2016 (Tromsø7) (C and D). The Tromsø Study 1994–2016.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Roth GA, Johnson C, Abajobir A, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017;70:1–25. doi: 10.1016/j.jacc.2017.04.052. - DOI - PMC - PubMed
    1. Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Public Health. 2021;21:401. doi: 10.1186/s12889-021-10429-0. - DOI - PMC - PubMed
    1. Bhatnagar P, Wickramasinghe K, Wilkins E, et al. Trends in the epidemiology of cardiovascular disease in the UK. Heart. 2016;102:1945–52. doi: 10.1136/heartjnl-2016-309573. - DOI - PMC - PubMed
    1. Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396:1204–22. doi: 10.1016/S0140-6736(20)30925-9. - DOI - PMC - PubMed
    1. Mensah GA, Wei GS, Sorlie PD, et al. Decline in Cardiovascular Mortality: Possible Causes and Implications. Circ Res. 2017;120:366–80. doi: 10.1161/CIRCRESAHA.116.309115. - DOI - PMC - PubMed

LinkOut - more resources